The introduction of TNF-a blocking agents is one of the milestones in the therapy of rheumatoid arthritis, parallel to the introduction of cortico-steroids. Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, the book charts the history and development of the concept of tumor-necrosis-factor-alpha (TNF-a) inhibition. The authors document TNF-a from its discovery to its now well-documented clinical applications in the treatment of patients with rheumatoid arthritis. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source for the most recent information in this field.
具體描述
讀後感
評分
評分
評分
評分
用戶評價
相關圖書
本站所有內容均為互聯網搜索引擎提供的公開搜索信息，本站不存儲任何數據與內容，任何內容與數據均與本站無關，如有需要請聯繫相關搜索引擎包括但不限於百度，google,bing,sogou 等
© 2025 book.quotespace.org All Rights Reserved. 小美書屋 版权所有